Navigation Links
Johnson & Johnson Establishes Susan Lindquist Chair for Women in Science
Date:11/16/2016

NEW BRUNSWICK, N.J., Nov. 16, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the establishment of the Susan Lindquist Chair for Women in Science to honor the life and legacy of Susan L. Lindquist, Ph.D., a globally renowned scientist whose intellectually courageous, boundary defying research significantly advanced science and medicine in the field of protein folding.  Dr. Lindquist, who passed away October 27, left behind a storied career and reputation in biomedical innovation that spanned basic research, entrepreneurship, and mentorship for women in science. The $5 million Chair is endowed in perpetuity at the Whitehead Institute for Biomedical Research and will be awarded to a female scientist to advance biomedical research.

"Sue was a scientific pioneer who changed fundamental understanding of the biology of human health. As part of the Johnson & Johnson Board of Directors, she challenged us to use science and technology in new ways to help improve the health and lives of people all around the world," said Alex Gorsky, Chairman and Chief Executive Officer of Johnson & Johnson. "We are pleased to establish this Chair in Sue's name as a greatly respected and beloved scientist and a passionate advocate for women in science."

An insightful leader with an incomparable perspective on the intersection of academic and commercial medical research, Dr. Lindquist's research changed the scientific community's understanding of protein folding and its role in human health, including diseases such as Parkinson's and Huntington's.  In addition to founding and co-founding multiple biotechnology companies, she served on the Johnson & Johnson Board of Directors since 2004 as Chairman of its Science, Technology & Sustainability Committee and as a member of its Regulatory, Compliance & Government Affairs Committee. When she joined the Whitehead Institute as both a Member and the Institute's Director in 2001, she became the Institute's first female head and one of the first women in the nation to lead a major independent research organization.

David C. Page, M.D., Director of the Whitehead Institute and Professor of Biology at the Massachusetts Institute of Technology (MIT), said, "We are so pleased to partner with Johnson & Johnson to honor Sue's legacy and the impact of women in science. In shaping the focus of this endowed Chair with Sue and Johnson & Johnson, our aim was to ensure the incumbents have great flexibility in how they pursue her legacy of stellar science and courageous leadership."

Dr. Lindquist's personal warmth and generosity were widely admired. As one colleague remembered, "she became one of my dearest mentors—never failing to check in on me, regularly inviting me to lunch to talk about the latest developments in our labs, even thinking to send me a gift to welcome my newborn son. Speaking with Sue always left me with a sense that everything was possible—that one could be a first-class scientist and a first-class human being. The world somehow expanded for all of us because she was in it. Sue made a point of lifting others up and championing younger people—she showed by example that this is how to have maximal impact."

"Sue changed the face of research in so many ways, and she will be deeply missed. We are pleased that her legacy and inspiration continues in her research and in support for other women in science through this new Chair," said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. "She was a phenomenal role model in all ways, to young men and women alike.  She was one of the finest people I have ever had the privilege to know."

Logo - http://photos.prnewswire.com/prnh/20160831/403394LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--johnson-establishes-susan-l-lindquist-chair-for-women-in-science-300364183.html


'/>"/>
SOURCE Johnson & Johnson
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. NantKwest Shareholder (NK) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of NantKwest, Inc.; Encourages Investors to Contact the Firm
2. Novira Therapeutics Announces Acquisition Agreement with Johnson & Johnson
3. OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers
4. enGene announces strategic collaboration with Johnson & Johnson innovation to develop novel gene delivery products for inflammatory bowel disease
5. Neurotech Announces Appointment of Dr. Charles Johnson as Chief Medical Officer
6. Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups
7. Johnson & Johnson Announces Collaboration between Janssen and USAID to Expand Access to Anti-Multidrug-Resistant Tuberculosis (MDR-TB) Compound
8. Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas
9. Conscires presents Certified Scrum Master Training by Lonnie Weaver-Johnson in Raleigh,NC
10. Certified Scrum Product Owner Training by Lonnie Weaver-Johnson in Richmond by Conscires Agile Practices
11. The Holistic Sanctuary Responds to Johnson & Johnson’s Guilty Plea for Selling Risperdal Off-Label
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... Basel, Switzerland (PRWEB) , ... May 23, 2017 ... ... for R&D, celebrates this month its 20th anniversary, marking the occasion with a ... is sponsoring the meeting’s Welcome Reception and further extends an invitation to all ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... ... publication of “Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology ... the result of a collaboration with Dr. Dino Di Carlo and Dr. Matthew Rettig ...
(Date:5/23/2017)... , ... May 23, 2017 , ... Bacterial biofilms, surface ... molecules, can cause diverse pathologies ranging from food poisoning and catheter infections to gum ... is in the tens of billions of dollars per year, there is currently a ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... Stratevi, a ... expanded to the East Coast. It has opened an office in downtown Boston at ... are finding it increasingly more important to generate evidence on the value they provide, ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):